PRL and autoimmune disease: We further examined the prognostic implications of baseline PRL levels on postoperative inflammatory/immune responses and evaluated bromocriptine’s therapeutic effects on immunoinflammatory parameters, aiming to investigate the potential association of PRL with these responses and to provide evidence supporting the hypothesis that GLM may be an autoimmune disease.